Novelty of bringing Technology to Ayurveda through the new concept of AyurTech

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

Round table Consultations on AYURTECH (Technology advancements) was held at International Engineering sourcing show at Chennai. The Joint event was organised by Ministry of AYUSH, SEPC and EEPC (Ministry of Commerce). Vaidya Rajesh Kotecha, Secretary, Ministry of Ayush was the...

Read More

Padma Shri to Prof Sudam Laxman Kate & Dr.Ashok Kukade for Medicine

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

President Kovind presents Padma Shri to Prof Sudam Laxman Kate for Medicine. He is a former Deputy Director, Tribal Health Research Project. B. J. Medical College, Pune. Prof Kale's pioneering research helped in prevention of sickle cell disease especially in...

Read More

Health Ministry takes stock of the public health measures for controlling West Nile Virus

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

A section of the media has reported that a seven year old boy from Malappuram District of Kerala is suffering from a West Nile Virus (WNV), a mosquito-borne disease, mostly reported in the continental United States. Union Minister of Health...

Read More

European Commission approves Roche’s Hemlibra for people with severe haemophilia

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

Roche has announced that the European Commission has approved Hemlibra (emicizumab) for routine prophylaxis of bleeding episodes in people with severe haemophilia A (congenital factor VIII deficiency, FVIII <1%) without factor VIII inhibitors. Hemlibra can be used in all age...

Read More

Nepal Investment seminar

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

Mr. Padmin Buch, Chairman, Foreign Trade committee, GCCI giving presentation on trade and treaty between Nepal and India. Hotel Four Points Sheraton. Seminar organized by GCCI and Nepal Embassy at Hotel Four Points Sheraton, Ahmedabad on March 14, 2019

Read More

Zydus receives final approval from the USFDA for 7 products

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

Zydus Cadila has received the final approval from the USFDA to market Valsartan and Hydrochlorothiazide Tablets USP (US RLD – Diovan HCT Tablets) in the strengths of 80 mg/12.5 mg, 160 mg/12.5 mg, 160 mg/25 mg, 320 mg/12.5 mg, and...

Read More

FDA announces new strategies to modernize clinical trials to advance precision medicine

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

Statement by FDA Commissioner Scott Gottlieb, M.D., on new strategies to modernize clinical trials to advance precision medicine, patient protections and more efficient product development: Modernizing clinical trials is an agency wide priority. As more diseases are being redefined based...

Read More

Innovation is the power which can bring prosperity: Dr. Ketan Patel

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

"Innovation is the power which can bring prosperity progress." This was stated by Dr Ketan Patel, Chairman & Managing Director of troikaa pharmaceuticals, who is recently appointed as Chairman of BoG at NIPER-Ahmedabad. Dr Patel was speaking at GTU Multidisciplinary...

Read More

Accuprec Director & Sr. Manager attended training programme on Implementation of ISO/IEC 17025:2

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

Ahmedabad Textile Industry's Research Association [ATIRA] organized a Training Program on 'Implementation of ISO/IEC 17025:2017 and Internal Audit'. The training programme was organised from 11th March to 14th March at ATIRA campus near AMA, Ahmedabad. Dr. Rina Gokani, Director &...

Read More

Claris VCMD talks about focus on quality of management

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

‘Enterprising Giants’, an event by TiE Ahmedabad, was organised on March 14, 2019 at Novotel. It invited home-grown successful entrepreneurs to share experiences on building value, staying ahead, and surviving tough times. Arjun Handa, Vice Chairman & MD of Claris,...

Read More

FDA takes action against marketer of unapproved products claiming to treat addiction, chronic pain a

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

The U.S. Food and Drug Administration today posted a warning letter to Nutra Pharma Corp. for illegally marketing unapproved products labeled as homeopathic with claims about their ability to treat addiction and chronic pain, including pain associated with cancer, diabetes,...

Read More

Zydus receives final approval from the USFDA for Acyclovir Ointment & Lurasidone Hydrochloride

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

Zydus Cadila has received the final approval from the USFDA to market Acyclovir Ointment USP (US RLD – Zovirax®), 5%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. Acyclovir is an antiviral drug which stops the...

Read More

Alcon Announces Acquisition of PowerVision, Inc.

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon's commitment to...

Read More

Actinium Appoints FDA Professional Mamata Gokhale as Vice President

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today the appointment of Mamata Gokhale, Ph.D., RAC as Vice President, Global Head of Regulatory Affairs. In this role, Dr. Gokhale will be responsible for developing and implementing a comprehensive clinical regulatory strategy...

Read More

FDA advances landmark policy changes to modernize mammography services and improve their quality

  • accuprec_admin
  • Comments : 0
  • July 7, 2021

U.S. Food and Drug Administration announced important new steps to modernize breast cancer screening and help empower patients with more information when they are considering important decisions regarding their breast health care. For the first time in more than 20...

Read More

Accreditations